Related Experiment Video
Updated: Apr 28, 2026

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
Published on: June 2, 2018
Sp1 is necessary for gene activation of Adamts17 by estrogen
Zanhui Jia1, Shuping Gao, Nadira M'Rabet
1Clinic of Gynecological Endocrinology and Reproductive Medicine, University of Basel, Spitalstrasse 21, CH-4031, Basel, Switzerland; Department of Biomedicine, University of Basel, Hebelstrasse 20, CH-4031, Basel, Switzerland; Department of Gynecology and Obstetrics, Second Hospital of Jilin University, Changchun City, Jilin Province, P.R. China.
Abstract:
Adamts17 is a member of a family of secreted metalloproteinases. In this report, we show that knockdown of Adamts17 expression induces apoptosis and inhibits breast cancer cell growth. Adamts17 expression can rapidly be induced by estrogens. siRNA knockdown of Sp1 or Myc demonstrated that Sp1 is required to induce Adamts17 gene expression in response to estrogen. Moreover, reporter assays showed that the proximal promoter and the upstream sequences were not capable of conferring estrogen responsiveness, suggesting that Sp1 elements may be located in the downstream intronic region. We further demonstrated that Sp1 and Myc binding in the proximal promoter region contributed to the Adamts17 basal expression. Furthermore, histone deacetylase (HDAC) and methylase inhibitors also induced Adamts17 expression, indicating that epigenetic alterations, such as aberrant HDAC and/or methylation are associated with dysregulated Adamts17 expression. By meta-analysis using Oncomine microarray data, we found that higher Adamts17 expression is found in several human cancer cell subtypes, especially in breast ductal carcinoma. Moreover, we found that there is an inverse correlation between higher Adamts17 expression and patients' survival. Our study suggests that Adamts17 may support breast cancer cell growth and survival.
Insights
Adamts17 (ADAM metallopeptidase domain 17) knockdown inhibits breast cancer growth and induces apoptosis. Estrogen rapidly induces Adamts17, regulated by Sp1 and epigenetic factors, suggesting Adamts17 promotes cancer survival.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Adamts17 (ADAM metallopeptidase domain 17) is a secreted metalloproteinase.
- Its role in cancer, particularly breast cancer, is not fully understood.
Purpose of the Study:
- To investigate the function of Adamts17 in breast cancer cell growth and survival.
- To elucidate the regulatory mechanisms of Adamts17 gene expression.
Main Methods:
- siRNA knockdown of Adamts17, Sp1, and Myc in breast cancer cells.
- Reporter assays to analyze promoter activity.
- Treatment with histone deacetylase (HDAC) and methylase inhibitors.
- Meta-analysis of Oncomine microarray data.
Main Results:
- Knockdown of Adamts17 inhibited breast cancer cell growth and induced apoptosis.
- Estrogen rapidly induced Adamts17 expression, dependent on Sp1 transcription factor.
- Sp1 binding elements may be located in intronic regions, contributing to estrogen responsiveness.
- Sp1 and Myc binding in the proximal promoter influenced basal Adamts17 expression.
- HDAC and methylase inhibitors increased Adamts17 expression, suggesting epigenetic regulation.
- Higher Adamts17 expression was observed in human breast ductal carcinoma subtypes.
- Elevated Adamts17 expression correlated inversely with patient survival.
Conclusions:
- Adamts17 plays a role in promoting breast cancer cell growth and survival.
- Adamts17 expression is regulated by estrogen, Sp1, and epigenetic modifications.
- Adamts17 represents a potential therapeutic target for breast cancer.
Related Concept Videos
Cell Specific Gene Expression
TGF - β Signaling Pathway
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...

